Chongqing Zhifei Biological Products (300122.CH) - Could Zhifei Support Its Valuation?
After its COVID-19 vaccine got approved in March, the investment logic is different. This article analyzed the key catalysts of Zhifei (agency...
329 Views
CanSino Biologics (6185.HK) - Will the COVID-19 Vaccine Be the Turning Point?
This article analyzed CanSino's core technology platforms, key products in the pipeline, insights on the products and core competitiveness and also...
416 Views
Industry Report - Insights on China Vaccine Industry
The article analyzed China vaccine industry in terms of market potential, key vaccine varieties such as PCV13, influenza vaccine, HPV vaccine,...
413 Views
Global Equity Rally Losing Upside Momentum
The global rally appears to be losing steam as the bearish rising wedge patterns we highlighted last week in the MSCI ACWI, ACWI ex-US, EM, and...
496 Views
SH/SZ Connect Flows: $6bn Outflows, Walvax, Wuxi Apptec, Dahua
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
368 Views